3 / 21
Page 37
Research & Reviews: Journal ofPharmaceutical Analysis | ISSN : 2320-0812
Euro Pharma Chemistry & Future Pharma 2019
June 27-28, 2019 | Amsterdam, Netherlands
12th World congress on
Joint Event
4
th
Pharmaceutical Chemistry Conference Future Pharma
Volume 08
Mostafa Alasmaey et al., Pharmaceutical Analysis 2019, Volume 08
Pure bio-active compounds from the Egyptian fungus Aspergillus
ASAI
T
he last two decades have shown that the fungi can be ‘bio-factories’ of bioactive
secondary metabolites with novel skeletons. Amongst the fungi Aspergillus
species are a rich source of structurally unique and biologically active secondary
metabolites. During the course of our investigation on bioactive natural products
frommicro-organisms, we found the extract of fungus ASAI was obtained from the
soil sample collected at Giza province, Egypt and identified as Aspergillus sp., it had
a promising activity against many pathogenic test organisms. Chromatographic
techniques isolation led to the isolation of nine pure compounds, which identified
by using 1D and 2D NMR and classified into three types: triterpene, quinone and
diketopiperazine alkaloid
.
Biography
Mostafa Alasmaey has completed his BSc in Organic Chemistry and MSc in Natural Product
Chemistry from Faculty of Science, Al-Azhar University, Egypt, and he is working as a Lecturer
Assistant in the same department from 2012. He is pursuing his PhD at Pharmacy School,
National and Kapodistrian University of Athens, Greece. He has published two papers in
reputed journals in the field of Natural Product Chemistry.
m167alasmae@yahoo.comCo-Author
Ahmed S Abdel-Razek
2
, Dennis
Abatis
1
, Nikolas Fokialakis
1
, Mohamed
Shaaban
2
and
Aligiannis Nektarios
1
1
National and Kapodistrian
University of Athens, Greece
2
National Research Centre, Egypt
Mostafa Alasmaey
National and Kapodistrian
University of Athens, Greece,
Al-Azhar University, Egypt